Available Technologies

Results

Removal of Ruthenium-Initiator from Brush-Arm Star Polymers (BASPs) via Core-to-Surface Ring-Opening Methathesis Polymerization (ROMP)

Technology / Case number: #19525
Jeremiah Johnson / Matthew Golder
Technology Areas: Biotechnology / Drug Delivery / Drug Discovery and Research Tools / Therapeutics
License

Sensitization of Bacterial Cells to Quinolone Antibiotic by Restoring High Energy Producing Metabolism

Technology / Case number: #20096
James Collins / Michael Lobritz / Arnaud Gutierrez
Technology Areas: Therapeutics
Impact Areas: Healthy Living
License

GLYCAN-BINDING PROTEINS AND RELATED COMPOSITIONS AND METHODS

Technology / Case number: #21107
Cristina Cella / Elizabeth Ward / Barbara Imperiali
Technology Areas: Diagnostics / Therapeutics
Impact Areas: Healthy Living
License

RNA-Based Regulatory Technologies for Improved miRNA Sensors

Technology / Case number: #19686
Ron Weiss / Kevin Lebo / Jin Huh
Technology Areas: Biotechnology / Drug Discovery and Research Tools / Therapeutics
License

Novel Peptidic Agents for Targeting Chemoresistant Anti-Apoptotic Bfl-1

Technology / Case number: #18607
Amy Keating / Justin Jenson
Technology Areas: Diagnostics / Drug Discovery and Research Tools / Therapeutics
Impact Areas: Healthy Living
License

Model-based Control for Column-based Continuous Viral Inactivation of Biopharmaceuticals

Technology / Case number: #21959
Richard Braatz / Amos Lu / Moo Sun Hong
Technology Areas: Biotechnology / Therapeutics
Impact Areas: Healthy Living
License

Structured DNA Nanoparticle Platform for Protein- and Peptide-based Vaccines

Technology / Case number: #20929H
Mark Bathe / Remi Veneziano / Rebecca Du / Tyson Moyer / Eike-Christian Wamhoff / Benjamin Read / Darrell Irvine
Technology Areas: Chemicals & Materials / Therapeutics
License

Alum-Binding Peptides for Prolonging Antigen Exposure and Augmenting Antigen-Specific Immune Responses

Technology / Case number: #19964HJ
Tyson Moyer / William Schief / Darrell Irvine
Technology Areas: Therapeutics
Impact Areas: Healthy Living
License

Mucin-inspired Glycopolymers Can Selectively Kill Vaginal Pathogen Gardnerella Vaginalis Without Impacting Growth of Beneficial Lactobacillus Crispatus

Technology / Case number: #24459
Katharina Ribbeck / Kelsey Wheeler / Caroline Werlang / Laura Kiessling / Spencer Brucks / Liubov Yakovlieva
Technology Areas: Chemicals & Materials / Drug Discovery and Research Tools / Therapeutics
Impact Areas: Healthy Living
License

The technologies listed represent a selection of the MIT intellectual property protected by the TLO.

filtered: 189 results

Sign up for technology updates

Sign up now to receive the latest updates on cutting-edge technologies and innovations.